Assessment of theca cell function prior to controlled ovarian stimulation: The predictive value of serum basal/stimulated steroid levels

Human Reproduction

Volumn 25, Issue 1, 2010, Pages 228-234

  Hugues, Jean Noël ^a   Theron Gerard, Lucie ^a   Coussieu, Christiane ^b   Pasquier, Maud ^a   Dewailly, Didier ^c   Cedrin Durnerin, Isabelle ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIV LILLE   (France)

Author keywords

Antral follicle count; Gonadotrophin releasing hormone agonist; In vitro fertilization; Theca cell function

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HYDROXYPROGESTERONE; MUELLERIAN INHIBITING FACTOR; STEROID; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; CLINICAL ASSESSMENT; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; OVARIAN RESERVE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; TESTOSTERONE BLOOD LEVEL; THECA CELL; TREATMENT RESPONSE;

EID: 72849137182     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep378     Document Type: Review

References (34)

1. Azziz R. Androgen excess is the key element in polycystic ovary syndrome. Fertil Steril 2003;80:252-254.
2. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro R, Norman RJ, Taylor AE et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-488.
3. Barbieri RL, Sluss PM, Powers RD, McShane PM, Vitonis A, Ginsburg E, Cramer DC. Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization. Fertil Steril 2005;83:302-308.
4. Barnes BR, Rosenfield RL, Burstein S, Ehrmann DA. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 1989;320:559-565.
5. Barth JH, Yasmin E, Balen AH. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin Endocrinol (Oxf) 2007;67:811-815.
6. Boots LR, Porter S, Potter HD, Azziz R. Measurement of total serum testosterone levels using commercially available kits. High degree of between kit variability. Fertil Steril 1998;69:286-292.
7. Broekmans FJ, Kwee J, Hendricks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
8. Chang LP, Lindheim SR, Lowre C, Ferin M, Gonzales F, Berglund L, Carmina E, Sauer M, Lobo RA. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab 2000;85:995-1000.
9. Davison SL, Bell R, Montalto JG, Sikaris K, Donath S, Stanczyck FZ, Davis SR. Measurement of total testosterone in women. Comparison of a direct radioimmunoassay versus radioimmunoassay after organic solvent extraction and celite column partition chromatography. Fertil Steril 2005;84:1698-1704.
10. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, De Palo R, Ranieri A, Colacurci N, Mollo A, on behalf of the Italian Collaborative Group on Recombinant Human Luteinizing Hormone. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005;20:390-396.
11. Ferraretti AP, Gianaroli L, Magli MC, D'Angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian stimulation for assisted reproduction techniques. Fertil Steril 2004;82:1521-1526.
12. Frattarelli JL, Gerber MD. Basal and cycle androgen levels correlate with in vitro fertilization stimulation parameters but do not predict pregnancy outcome. Fertil Steril 2006;86:51-57.
13. Frattarelli JL, Peterson EH. Effect of androgen levels on in vitro fertilization cycles. Fertil Steril 2004;81:1713-1714.
14. Hillier SG, Tetsuka M, Fraser H. Location and developmental regulation of androgen receptor in primate ovary. Hum Reprod 1997;12:107-111.
15. Horie K, Takakura K, Fujiwara H. Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Hum Reprod 1992;7:184-190.
16. Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod BioMed Online 2004; 8:635-643.
17. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003;18:598-603.
18. Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin alpha) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod BioMed Online 2003;8:175-182.
19. McCartney CR, Bellows AB, Gingrich MB, Hu Y, Evans WS, Marshall JC, Veldhuis JD. Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome. Am J Physiol Endocrinol Metab 2004;286:E902-E908.
20. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanskyi A. Measurement of free testosterone in normal women and women with androgen deficiency. Comparison of methods. J Clin Endocrinol Metab 2004;89:525-533.
21. Nelson VL, Qin K, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss JF 3rd, McAllister JM. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86: 5925-5933.
22. Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. J Clin Endocrinol Metab 2007;11:4208-4217.
23. Piltonen T, Koivunen R, Ruokonen A, Tapanainen JS. Ovarian age-related responsiveness to human chorionic gonadotropin. J Clin Endocrinol Metab 2003;88:3327-3332.
24. Rosenfield RL, Ehrmann DA, Barnes RB, Sheikh Z. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann N Y Acad Sci 1993;687:162-181.
25. Rosenfield RL, Barnes RB, Ehrmann DA. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1994;79:1686-1692.
26. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group revised on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
27. Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro procedures. Fertil Steril 2007;87: 542-546.
28. Sahin Y, Kelestimur F. 17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation. Hum Reprod 1997;12:910-913.
29. Suikkari AM, McLachlan V, Montalto J, Calderon I, Healy D, McLachlan RI. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment. Hum Reprod 1995;10:513-519.
30. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-2629.
31. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
32. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, Bondy CA. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 1998;83:2479-2485.
33. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-2956.
34. Zawadzki J, Dunaif A. Diagnosis criteria for polycystic ovary syndrome: towards a rational approach. In Dunaif A, Givens JR, Haseltine FP, Merriam GR (eds). Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific Publications, 1992, 377-384.